Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2024

  1. Concordance in the estimation of tumor percentage in non-small cell lung cancer using digital pathology

    Scientific Reports, Vol. 14, Núm. 1

  2. RET Fusion Testing in Patients With NSCLC: The RETING Study

    JTO Clinical and Research Reports, Vol. 5, Núm. 4

2020

  1. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

    Cancer Biology and Medicine, Vol. 17, Núm. 2, pp. 444-457

2019

  1. Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

    Journal of Thoracic Oncology, Vol. 14, Núm. 12, pp. 2120-2132

2017

  1. HIV, HPV, and microbiota: Partners in crime?

    AIDS, Vol. 31, Núm. 4, pp. 591-594

  2. Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM

    PLoS ONE, Vol. 12, Núm. 11

2014

  1. Accurate identification of ALK positive lung carcinoma patients: Novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

    PLoS ONE, Vol. 9, Núm. 9

1999

  1. Valor predictivo de la proteina p53 en los tumores avanzados de cabeza y cuello tratados con quimioterapia

    Oncologia, Vol. 22, Núm. 5, pp. 56-61

  2. p53 expression in locally advanced pharyngeal squamous cell carcinoma

    Archives of Otolaryngology - Head and Neck Surgery, Vol. 125, Núm. 12, pp. 1356-1359